CCDC86 Antikörper (AA 101-150)
-
- Target Alle CCDC86 Antikörper anzeigen
- CCDC86 (Coiled-Coil Domain Containing 86 (CCDC86))
-
Bindungsspezifität
- AA 101-150
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CCDC86 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- Human CCDC86
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide located between aa101-150 of human CCDC86 (Q9H6F5, NP_077003). Percent identity by BLAST analysis: Human (100%).
Type of Immunogen: Synthetic peptide
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Distilled water
- Konzentration
- Lot specific
- Buffer
- Lyophilized from PBS
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
- Target
- CCDC86 (Coiled-Coil Domain Containing 86 (CCDC86))
- Andere Bezeichnung
- CCDC86 (CCDC86 Produkte)
- Synonyme
- DKFZp469C0939 antikoerper, 4933411H20Rik antikoerper, 6720480F16Rik antikoerper, D19Ertd678e antikoerper, coiled-coil domain containing 86 antikoerper, CCDC86 antikoerper, Ccdc86 antikoerper
- Hintergrund
-
Name/Gene ID: CCDC86
Synonyms: CCDC86, Cyclon - Gen-ID
- 79080
- NCBI Accession
- NP_077003
- UniProt
- Q9H6F5
- Pathways
- SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion
-